Advertisement

Comparison of initial splectomy and spleen irradiation in Clinical Stages I and II Hodgkin’s disease

  • M. Hayat
  • P. Carde
Chapter
Part of the Developments in Oncology book series (DION, volume 32)

Abstract

From 1972 to 1976, the EORTC Radiotherapy-Chemotherapy Group carried out its second controlled clinical trial (H2 trial) in Clinical Stages (CS) I and II Hodgkin’s disease. Prior to the commencement of this trial, laparotomy with plenectomy had been introduced at Stanford as a new and more appropriate procedure for staging patients with CS I and II [1].

Keywords

Small Bowel Obstruction Gastroduodenal Ulcus Relapse Free Survival Lymphoid Depletion Favorable Prognostic Indicator 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Glatstein E, Guernsey JM, Rosenberg SA and Kaplan HS (1969). The value of laparotomy and splenectomy in the staging of Hodgkin’s disease. Cancer 24: 709–718.PubMedCrossRefGoogle Scholar
  2. 2.
    Tubiana M, Hayat M, Henry-Amar M et al. (1981). Five-year results of EORTC randomized study of splenectomy and spleen irradiation in Clinical Stages I and II of Hodgkin’s disease. Eur J Cancer 17: 355–363.PubMedCrossRefGoogle Scholar
  3. 3.
    Cox DR (1972). Regression model and life tables. J Roy Stat Soc B 34: 187–220.Google Scholar

Copyright information

© Martinus Nijhoff Publishers, Boston 1985

Authors and Affiliations

  • M. Hayat
    • 1
  • P. Carde
    • 1
  1. 1.EORTC Radiotherapy-Chemotherapy GroupInstitut Gustave-RoussyVillejuifFrance

Personalised recommendations